dan 2163 has been researched along with Cardiometabolic Syndrome in 2 studies
Cardiometabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components not only include metabolic dysfunctions of METABOLIC SYNDROME but also HYPERTENSION, and ABDOMINAL OBESITY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CK | 1 |
| Hung, GC | 1 |
| Hong, CC | 1 |
| Chen, CK | 1 |
| Yeh, TC | 1 |
| Chu, CS | 1 |
| Chen, TY | 1 |
2 other studies available for dan 2163 and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Amisulpride-associated acute onset of metabolic syndrome in a schizophrenia patient.
Topics: Adult; Amisulpride; Antipsychotic Agents; Female; Humans; Metabolic Syndrome; Schizophrenia; Sulpiri | 2013 |
Amisulpride monotherapy may be a choice of maintenance treatment for patients with both bipolar I disorder and metabolic syndrome.
Topics: Amisulpride; Antipsychotic Agents; Bipolar Disorder; Humans; Male; Metabolic Syndrome; Sulpiride; Yo | 2015 |